3-Hydroxypyridine → HCID 21906079, compound

HRID 2305747Notes

Reaction equation

HRID 2305747 reaction equation
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH:11]([OH:14])[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].O[C:16]1[CH:17]=[N:18][CH:19]=[CH:20][CH:21]=1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.N(C(OCC)=O)=NC(OCC)=O>O1CCCC1>[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH:11]([O:14][C:16]2[CH:17]=[N:18][CH:19]=[CH:20][CH:21]=2)[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:2])[CH3:3]

Participants

6

Procedure

Under a nitrogen atmosphere, a cold (0-5° C.), stirring solution of N-(tert-butoxycarbonyl)-piperidin4-ol (800 mg, 3.98 mmol), 3-hydroxypyridine (378 mg, 3.98 mmol) and triphenylphosphine (1.148 g, 4.38 mmol) in dry tetrahydrofuran (20 mL) was treated drop-wise via syringe with diethyl azodicarboxylate (0.75 mL, 830 mg, 4.76 mmol). The mixture was allowed to stir and warm to ambient temperature over 16 h. The solvent was removed by rotary evaporation, and the crude product was purified by column chromatography over silica gel, eluting with hexane-ethyl acetate (9:1, v/v). Selected fractions were collected and concentrated to produce 800 mg (72.2%) of a thick syrup.

Workup

  1. customThe solvent was removed by rotary evaporation
  2. customthe crude product was purified by column chromatography over silica gel
  3. washeluting with hexane-ethyl acetate (9:1
  4. customSelected fractions were collected
  5. concentrationconcentrated

Sources & evidence

ORD record
ord-e17f9f411e204a4e822a86184203eb2e
Source dataset
uspto-grants-2002_08
Patent number
US06441006B2

Reaction notes

Loading…